Lexaria closes warrant exercise for about $5.9 million in gross proceeds
Lexaria Bioscience Corp. closed its previously announced exercise of outstanding warrants, raising approximately $5.9 million in gross proceeds. The company says the warrants covered an aggregate of 453…